Saturday, July 11, 2026

pharma · HR-positive, HER2-negative Advanced Breast Cancer · Hyperglycemia

Chia Tai Tianqing

Chia Tai Tianqing drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Lianyungang, CN HQ
366 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Lianyungang, CN
Employees
366
Programs
2
Drugs
3
Patents
0
Intelligence · Drug Pipeline

Chia Tai Tianqing pipeline

Portfolio lens on 3 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Chia Tai Tianqing drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Drug portfolio

3 compounds
  1. Development asset linked to Chia Tai Tianqing in public FDA and regional records.

  2. Development asset linked to Chia Tai Tianqing in public FDA and regional records.

  3. Development asset linked to Chia Tai Tianqing in public FDA and regional records.